Managed Care Pharmacy Practice
|
|
- Augusta Hancock
- 6 years ago
- Views:
Transcription
1 Managed Care Pharmacy Practice Robert P. Navarro, Pharml) Principal NavarroPharma, LLC Morrisville, North Carolina Senior Vice President MediMedia Managed Care, I.I.C Trenton, New Jersey AN ASPHN" PUBLICATION' Aspen Publishers. Inc. (iaithersburg. Man land
2 Table of Contents Contributors Foreword Preface Acknowledgments xvii xxi xxiii xxv PART I FUNDAMENTALS OF MANAGED CARE PHARMACY BENEFIT MANAGEMENT 1 Judith A. Cahill, Part Editor Chapter 1 The U.S. Health Care System and the Development of Managed Care 3 Robert P. Navarro and Judith A. Cahill Introduction to U.S. Health Insurance Industry 4 Evolution of the Health Insurance Industry 6 Economic Basis for the Development of Managed Care 7 Early Development of Managed Care 8 HMO Act of Federal and State Growth in Managed Care: Medicare and Medicaid 13 MCOs: More than HMOs 14 Physician Reimbursement Mechanisms 19 Gatekeeper Physicians 22 Risk Sharing of Pharmacy Cost 22 Carve-Out and Ancillary Health Care Benefits 22 Quest for Quality 23 Impact of Managed Care on Physicians and Pharmacists 24 Member Involvement in Managed Care 26 Conclusion 27
3 vi MANAGED CARE PHARMACY PRACTICE Chapter 2 Pharmacy Benefit Management Principles and Practices 29 Robert P. Navarro Basis for Pharmacy Benefit Management 29 Principles of Pharmacy Benefit Management 32 Growth of PBMs 33 Pharmacy Benefit Management Program Components 36 Advanced Pharmacy Benefit Management Components 43 Measuring Pharmacy Benefit Management Program Performance 43 Conclusion 45 Chapter 3 Pharmacy Benefit Design, Contracting, and Marketing John D. Jones Business Basis for Pharmacy Benefit Management 47 Corporate and Government Impetus for Pharmacy Benefit Management 49 Legal Basis of Pharmacy Benefit Management 50 Benefit Design, State Requirements 52 Principles of Marketing Pharmacy Benefits 53 Payer and Patient Expectations and Decision Points 55 Role of Members in Pharmacy Benefit Provider Selection 57 Pharmacy Performance Measurements Important in Marketing 59 Marketing Campaign Advertisement Examples 60 Marketing Process 60 Pharmacy Benefit Contracting Components 62 Pharmacy Benefit Management Contracting Trends 64 Risk Contracting 65 Overview of Impact of Medicare and Medicaid 65 Risk-Contracting Elements and Executions 68 Payer Expectations 70 Performance Measurement 72 Future Trends in Pharmacy Benefit Design and Contracting 73 Conclusion 76 Appendix 3-A 77 Appendix 3-B 83
4 Table of Contents vii Chapter 4 Pharmacy Distribution Systems and Network Management 89 Lowell T. Sterler and Douglas Stephens Pharmacy Program Distribution Options 90 Community Pharmacy Provider Networks 90 Pharmacy Provider Network Development 92 Pharmacy Provider Network Contracting 93 Participating Pharmacy Provider Agreement 94 Participating Pharmacy Provider Manual 95 Participating Pharmacy Network Management Issues 95 Measuring Performance 97 Audits 98 Reports 100 Member Satisfaction 100 In-House Pharmacies 101 Mail Service Pharmacy 107 Developing an Integrated Distribution System 108 Pharmacist's Role Ill Impact of Managed Care on the Profession of Pharmacy 114 Conclusion 114 Appendix 4-A 116 Chapter 5 Pharmacy Data and Information Systems 125 John H. Romza and Garth E. Black Scope of Pharmacy Information Management 125 Pharmacy Information Management Systems 127 PMSs and Electronic Data Interchange 134 Role of Switching Companies 135 Internet Technology 137 Adjudication Systems 138 Other MCO Information Systems 141 Conclusion 143 Chapter 6 Drug Formulary Management 145 Michael J. Dillon History and Purpose of Drug Formularies 145 Definitions 147 Why Formularies? 148
5 viii MANAGED CARE PHARMACY PRACTICE Decision-Making Process 151 Formulary Exception Process 157 Formularies' Relationship to Other Pharmaceutical Care Practices 158 Future Directions 161 Conclusion 163 Chapter 7 Drug Utilization Review Strategies 167 Andrew M. Peterson and Marcus D. Wilson History and Current Role of DUE/DUR 167 Types of DURs 170 Steps in Conducting DURs 173 Application of DUR in Pharmacy Benefit Management 175 Prior Authorization 176 Prospective DUR 178 Physician Education Programs 179 Performance Measurement of DUR Programs 180 Evolution of DUR 181 Conclusion 182 Chapter 8 Member Satisfaction Strategies 185 Jim Wilson and Shawn Burke Importance of Member Satisfaction 186 National Committee for Quality Assurance and Health Plan Employer Data and Information Set 189 Satisfaction Measurement among Employer Groups 191 Member Satisfaction with Pharmacy Benefits 192 Conclusion 197 Chapter 9 Pharmacy Program Performance Measurement 199 Yrena M. Friedmann and Nicholas A. Hanchak Role of Pharmacy Benefits in Overall Health Plan Performance 199 Pharmacy Performance Metrics 200 Measuring Performance of Various Components 207 Interpreting Results of Pharmacy Measurement 208 Interpreting Cost Metrics 208 Communication of Pharmacy Program Results 210 Application of Results for Program Improvement 212
6 Table of Contents ix Advanced Outcomes Management Metrics 216 Linking Pharmacy Programs to Overall Medical and Economic Outcomes 219 Conclusion 220 Chapter 10 Pharmacy Benefit Management Companies 221 Robert P. Navarro and Suzanne S. Blackburn Genesis of PBMs 221 Growth and Evolution of PBMs 226 Outsourcing Pharmacy Benefit Management to a PBM 230 Financial Arrangement between PBMs and Their Customers 236 Projecting Cost Savings Using PBM Services 237 Reintegrating the Value of PBM Services 238 Contracting for PBM Services 239 Conclusion 240 PART II ADVANCED PHARMACY BENEFIT MANAGEMENT STRATEGIES 243 Robert P. Navarro, Part Editor Chapter 11 Medicaid Pharmacy Benefit Management 245 Mary Kay Owens Legislative History 245 Administration of Medicaid Benefits 247 Funding Medicaid Benefits 248 Medicaid Eligibility 248 Medicaid Services 249 Medicaid Benefit Design 250 Managed Care Waivers 250 Medicaid Managed Care Contracts 251 Performance Measures and Member Satisfaction 252 Medicaid Pharmacy Benefit Design 252 OTC Product Coverage 253 Medicaid Prescription Copayments 253 Dispensing Fees 254 Pharmaceutical Manufacturer Rebates 255 Challenges and Opportunities in Medicaid Pharmacy Benefit Management 255 Medicaid Demographic Challenges 255
7 MANAGED CARE PHARMACY PRACTICE Developmental and Cultural Issues 256 Traditional Fee-For-Service Medicaid Benefit Management Challenges 257 Managed Care Challenges in Providing Medicaid Benefits Pharmacy Benefit Management Opportunities 261 Future Managed Care Medicaid Trends 264 Conclusion 267 Chapter 12 Medicare Pharmacy Benefit Management 269 Debi Reissman The Social Security Act of 1965 and the Tax Equity and Fiscal Responsibility Act 269 Benefits Covered under Medicare 272 Types of Medicare Programs 272 Why Medicare Enrollees Prefer HMOs to Traditional Medicare 274 Prescription Use and the Medicare Patient 275 Management of the Medicare Prescription Drug Benefit Location of Network Pharmacies 277 Drug Formularies 277 Mail Order 280 Drug Utilization Review 280 The Future of Medicare 281 Conclusion 281 Chapter 13 Quality Improvement Initiatives in Managed Care 285 Amelia Goodwin Defining Quality Health Care 285 Assigning Accountability 289 Measuring Quality 290 Current Quality Improvement Initiatives 293 NCQA 294 Joint Commission 297 American Accreditation Healthcare Commission/The Utilization Review Accreditation Commission 302 FACCT 303 AHCPR 304 HCFA 306 Other Quality Improvement Initiatives 306 Future of Quality Measurement in Managed Care 307
8 Table of Contents xi Role of Pharmacists 309 Conclusion 311 Chapter 14 Health Informatics Systems 313 Robert P. Navarro, Robert Da Silva, and Suzanne Rivkin Evolution of Pharmacy Data Standardization 314 EDI and Electronic Commerce 315 Data and Information Needs of Managed Care 318 Pharmacy and Medical Claims Integration 324 Electronic Medical Record Data 328 Building a Data Warehouse 332 Patient Outcomes Assessment 336 Electronic Prescribing 337 Merging Retrospective and Transactional Data 340 Pharmacy and Health Telematics 341 On-Line Patient Marketing 342 Conclusion 343 Chapter 15 Provider and Vendor Risk Contracts 347 Craig S. Stern, Carol J. Stern, and John M. Cronin Pharmacy Risk Contracting 347 Physician Risk Contracts 352 Reimbursement Agreements 359 Choosing a Reimbursement Methodology 364 Quality Issues 365 Forecast 366 Conclusion 368 Chapter 16 Disease Management Programs 371 Robert P. Navarro, Dale Christensen, and Harry: Leider Definition and Goals 372 Rationale 374 Medical Conditions Appropriate for Disease Management Disease Management Process 376 Growth of Disease Management 378 Role of Pharmacy Benefit Management Companies 378 Pharmaceutical Manufacturer Role in Disease Management. 379 Role of Physicians in Disease Management 380 Role of Pharmacists in Disease Management 382
9 xii MANAGED CARE PHARMACY PRACTICE Role and Source of Disease Management Guidelines 386 Role of Drug Formularies in Disease Management 388 Modifying Participant Behavior 388 Barriers to Successful Programs 391 Specialty Carve-Out and Carve-In Disease Management Companies 391 Measuring Program Performance 392 Conclusion 392 Chapter 17 Pharmacoeconomic Research and Applications in Managed Care 397 Diana I. Brixner, Sheryl L. Szeinbach, Shilpa Mehta, Seonyoung Ryu, and Hemal Shah Basics of Pharmacoeconomic Research 400 Application of Pharmacoeconomics in Pharmaceutical Companies 402 Use of Pharmacoeconomic Data for Effectiveness Claims Role of Pharmacoeconomic Research in Product Management 408 Pharmacoeconomic Information Strategies within Pharmaceutical Companies 410 Packaging Pharmacoeconomic Data for Use by P & T Committees 413 Role of Pharmacoeconomic Data in Evidence-Based Drug Formularies 416 Research Opportunities for Managed Care Organizations and PBMs 418 Role of Pharmacoeconomics in Decompartmentalizing Plan Management 418 Sources of Data 423 Opportunities for Pharmacists in Pharmacoeconomic Research and Applications 428 Conclusion 429 Chapter 18 The Role of the Pharmaceutical Industry in Managed Health Care 433 Stephen Stefano and Robert P. Navarro Influence of Managed Care on the Sales of Pharmaceuticals Relationship of Pharmaceutical Manufacturers to Managed Care 435
10 Table of Contents xiii Evolution of the Pharmaceutical Marketplace 435 Managed Care Marketing Strategy Development 442 Contractual Relationships between the Pharmaceutical and Managed Care Industries 443 Pharmaceutical Company Support Services for Managed Care 445 Future Relationship of Pharmaceutical Manufacturers with Managed Care 447 PART III PHARMACY PRACTICE ISSUES IN MANAGED CARE 449 Albert I. Wertheimer, Part Editor Chapter 19 The Impact of Managed Care on Pharmacy Practice Kenneth W. Schafermeyer Impact of Managed Care Programs on Pharmacy 452 Reimbursement for Managed Care Prescriptions 454 Administration of Managed Care Prescription Contracts Managed Care Strategies for Pharmacists 466 Effect of Managed Care on Hospital Pharmacies 470 Conclusion 471 Chapter 20 Pharmaceutical Care in Managed Care 475 Leslie S. Fish Current Trends 476 Examples of Pharmaceutical Care in Managed Care 480 Impact of Pharmaceutical Care in Managed Care: Cost and Quality 488 Reimbursement for Pharmaceutical Care: Cognitive Services Conclusion 493 Chapter 21 Pharmacist Career Path Opportunities in Managed Care 497 Carl E. Trinca The Future of Pharmacy under Managed Care 497 Preparing for a Career in Managed Health Care 499 Novel Career Opportunities 501 Maintaining Career Viability 501
11 xiv MANAGED CARE PHARMACY PRACTICE Questions Surrounding an Uncertain Future 502 Professional Responsibilities toward Career 504 Conclusion 504 Chapter 22 Ethical Aspects of Pharmacy Practice in Managed Care 507 Mila Ann Aroskar Examples of Ethical Issues and Concerns 508 Ethical Values: Their Place in Pharmacy Practice 511 Ethical Principles and Concepts in Pharmacy Practice 516 Resources for Managing Ethical Concerns in Pharmacy Practice 520 Conclusion 523 Chapter 23 Drug Policy and Regulation in Managed Care 525 Natalie A. Spencer and M. Therese Crouse Food and Drug Administration Issues 525 Direct-to-Consumer Advertising 531 Patient "Bill of Rights" Initiatives 532 Patient Privacy Issues 536 Fraud and Abuse and Consumer Protection Legislation 541 Therapeutic Interchange 543 Narrow Therapeutic Index Drugs 545 Employee Retirement Income Security Act 547 Licensing 550 Any Willing Provider and Freedom of Choice Legislation Mail Service Pharmacies 553 Conclusion 554 Chapter 24 International Opportunities for Pharmacists in Managed Care 557 Albert I. Wertheimer Managed Care Techniques 560 Austria 562 Denmark 562 Finland 562 France 563 Germany 563 Italy 563
12 Table of Con ten ts xv The Netherlands 563 Norway 564 Sweden 564 Switzerland 564 United Kingdom 565 Career Opportunities Abroad 565 Conclusion 567 Chapter 25 Future of Pharmacy Benefit Management 571 Robert P. Navarro Forces of Change 572 Reaction and Interaction of Change Forces 574 Impact of Forces of Change 575 Pharmacy Practice in the Year 2000 and Beyond 589 Conclusion 590 Glossary 593 About the Contributors 625 Index 632
PHARMACY BENEFIT MANAGER (PBM)
PHARMACY BENEFIT MANAGER (PBM) Presentation by: Pantea Ghasemi, USC Pharm.D. Candidate of 2015 Mentor: Dr. Craig Stern, Pro Pharma Consultants Inc. April 3, 2015 OBJECTIVES 1. Define PBM 2. Discuss Service
More informationHEALTH ECONOMICS AND FINANCING
HEALTH ECONOMICS AND FINANCING Fourth Edition Thomks E. Getzen Temple University WILEY JOHN WILEY & SONS, INC. Preface xxi Acknowledgments About the Author xxiii xxiii Foreword 1 Choices: Money, Medicine,
More informationSecond Edition HAP AUPHA. Health Administration Press, Chicago, Illinois
HEALTH INSURANCE Second Edition MICHAEL A. MORRISEY HAP AUPHA Health Administration Press, Chicago, Illinois Association of University Programs in Health Administration, Arlington, Virginia BRIEF CONTENTS
More informationGlossary of Terms (Terms are listed in Alphabetical Order)
Glossary of Terms (Terms are listed in Alphabetical Order) Access Access refers to the availability and location of pharmacies that participate in the network that serves your pharmacy benefit plan. Acute
More informationModernizing Louisiana s Medicaid
Modernizing Louisiana s Medicaid Pharmacy Program Prescription for Reform F i n a l R e f o r m C o n c e p t August 24, 2012 Modernizing Louisiana s Medicaid Pharmacy Program Our Vision: Principles for
More informationCommon Managed Care Terms & Definitions
Contact Us: Email: info@emedbiz.com Phone: 561-430-2090 Fax: 561-430-2091 Website: www.emedbiz.com Common Managed Care Terms & Definitions Balance billing: The practice of billing a patient for the amount
More informationSubject: Pharmacy Services & Formulary Management (Page 1 of 5)
Subject: Pharmacy Services & Formulary Management (Page 1 of 5) Objective: I. To ensure the clinically appropriate prescription and use of pharmaceuticals by Tuality Health Alliance (THA) providers and
More informationThe Pharmaceutical Industry, Drug Prices and Value
The Pharmaceutical Industry, Drug Prices and Value Pharma, Biotech and Device Colloquium at Princeton University Humphrey Taylor June 9, 2004 www.harrisinteractive.com 2003, All rights reserved. Topics
More informationSelectHealth Prescriptions
SelectHealth Prescriptions pharmacy benefit management program SM SelectHealth Prescriptions is a full-service Pharmacy Benefit Manager (PBM) that offers transparent pricing, clinically based programs,
More informationSavings Generated by New York s Medicaid Pharmacy Reform
Savings Generated by New York s Medicaid Pharmacy Reform Sponsored by: Pharmaceutical Care Management Association Prepared by: Special Needs Consulting Services, Inc. October 2012 Table of Contents I.
More informationLindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy
Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy Under the Preceptorship of Dr. Craig Stern Pro Pharma Pharmaceutical Consultants, Inc. September 11, 2015 S OBJECTIVES
More informationPharmacy Benefit Managers Overview
Pharmacy Benefit Managers Overview A Presentation to the House Health Innovation Subcommittee Mary Alice Nye, Ph.D. Health and Human Services Staff Director, OPPAGA December 6, 2017 Pharmacy Benefit Managers
More informationDepartment of Management Services REQUEST FOR INFORMATION. Comprehensive Surgical and Medical Procedures Entity
Pursuant to 60A-1.042, an agency may request information by issuing a written Request for Information. Agencies may use Requests for Information in circumstances including, but not limited to, determining
More informationState Employees' Group Health Self-Insurance Trust Fund
State Employees' Group Health Self-Insurance Trust Fund Report on the Financial Outlook For the Fiscal Years Ending June 30, 2012 through June 30, 2016 Presented January 4, 2012 Prepared by: Florida Department
More informationBRIEF CONTENTS. Preface...xv Acknowledgments...xvi. Part I: Financial Management. Chapter 1 Financial Management in Context... 3
BRIEF CONTENTS Preface...xv Acknowledgments...xvi Part I: Financial Management Chapter 1 Financial Management in Context... 3 Chapter 2 Organization of Financial Management... 31 Chapter 3 Financial Analysis
More informationAugust 4, The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C.
August 4, 2009 The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C. 20515 The Honorable Henry A. Waxman, Chairman Committee on Energy
More informationSecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals
SecurityBlue HMO Conditions and Limitations Potential for Contract Termination Disenrollment Rights and Instructions Exceptions, Prior Authorization, Appeals and Grievances Out-of-Network Coverage Quality
More informationPrescription Drug Benefit Plans: A Buyer s Guide. chcf
chcf Prescription Drug Benefit Plans: A Buyer s Guide January 2003 Prescription Drug Benefit Plans: A Buyer s Guide Prepared for CALIFORNIA HEALTHCARE FOUNDATION by Mercer Human Resource Consulting chcf
More informationThe U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD
The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use Presented by Daniel Tomaszewski Pharmd, PhD 1 Medical Vs. Pharmacy Coverage Medical Insurance Managed by an Insurance
More information**BEGINNING OF EXAMINATION** HEALTH, GROUP LIFE & MANAGED CARE MORNING SESSION
**BEGINNING OF EXAMINATION** HEALTH, GROUP LIFE & MANAGED CARE MORNING SESSION 1. (4 points) You are an actuary for a reinsurance company. A business school professor at a local university has invited
More informationBlue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy
Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - In this Section there are references unique to Blue Essentials, Blue Advantage HMO and Blue Premier. These network specific
More informationGLOSSARY OF USEFUL HEALTH INSURANCE TERMS
Data Decisions Delivery Directing Comprehensive TA: From Systems to Sustainability GLOSSARY OF USEFUL HEALTH INSURANCE TERMS This glossary is adapted from an array of resources to improve the health insurance
More informationIowa Medicaid Synopsis of Managed Medicaid Request for Proposal
Iowa Medicaid Synopsis of Managed Medicaid Request for Proposal The following information provides summary information of key aspects of the Iowa Medicaid Request For Proposal SOW for Capitated Managed
More informationThe Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers
CONTEMPORARY SUBJECT The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers DANIEL C. WALDEN, JD, and ROBERT
More informationApproach to Employment Injury (EI) compensation benefits in the EU and OECD
Approach to (EI) compensation benefits in the EU and OECD The benefits of protection can be divided in three main groups. The cash benefits include disability pensions, survivor's pensions and other short-
More informationMoving From PBM to PBA Model
Moving From PBM to PBA Model Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy Pro Pharma Pharmaceutical Consultants, Inc. Under the preceptorship of Dr. Craig Stern
More informationSan Francisco Health Service System Health Service Board
San Francisco Health Service System Health Service Board HSS Rates & Benefits Committee Meeting City Plan (UHC) Employer Group Waiver Plan (EGWP) + Wrap Presentation April 12, 2012 Prepared by Aon Hewitt
More informationFINANCING ENERGY PROJECTS IN DEVELOPING COUNTRIES
FINANCING ENERGY PROJECTS IN DEVELOPING COUNTRIES HOSSEIN RAZAVI, PHD CONTENTS List of Executive Overviews Summaries Figures Tables Preface Acknowledgments Abbreviations and Acronyms Units and Conversion
More informationINFORMATION ABOUT YOUR OXFORD COVERAGE
OXFORD HEALTH PLANS (CT), INC. INFORMATION ABOUT YOUR OXFORD COVERAGE PART I. REIMBURSEMENT Overview of Provider Reimbursement Methodologies Generally, Oxford pays Network Providers on a fee-for-service
More informationIntroduction to the US Health Care System. What the Business Development Professional Should Know
Introduction to the US Health Care System What the Business Development Professional Should Know November 2006 1 Understanding of the US Health Care System Evolution of the US health care system to its
More informationThe Management of Specialty Drugs: Opportunities and Challenges
The Management of Specialty Drugs: Opportunities and Challenges Scott Woods Senior Director, Policy PCMA Innovations X April 5, 2016 Specialty Drugs to be Half of Spend by 2018 Forecast PMPM Net Drug
More informationPROVIDER TYPE SPECIFIC PACKET/CHECKLIST
PROVIDER TYPE SPECIFIC PACKET/CHECKLIST (Louisiana Medicaid Program) PHARMACY (Enrollment packet is subject to change without notice) PT 26 Revised 02/14 Pharmacy CHECKLIST OF FORMS TO BE SUBMITTED The
More informationEvaluation of Savings from Pharmaceutical Interventions. Robin Lunge Steve Kappel January 26, 2007
Evaluation of Savings from Pharmaceutical Interventions Robin Lunge Steve Kappel January 26, 2007 Ways to Achieve Savings Any effort to address savings must have an effect on prices, utilization, or intensity,
More informationCARECOUNSEL TIPS SELECTING A HEALTH PLAN. Step 1: Gather Basic Information. Step 2: Assess Your Needs
SELECTING A HEALTH PLAN Choosing between health plans is no longer a simple matter. As a healthcare consumer, it s important that you educate yourself about the various health plans available to you. You
More informationOverview of Coverage of Drugs Under the Medicaid Medical Benefit
Overview of Coverage of Drugs Under the Medicaid Medical Benefit June 4, 2008 Amanda Bartelme Avalere Health LLC Avalere Health LLC The intersection of business strategy and public policy Medical vs. Pharmacy
More informationTestimony of Mark Merritt. Pharmaceutical Care Management Association
Testimony of Mark Merritt Pharmaceutical Care Management Association Before the UNITED STATES SENATE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS The Cost of Prescription Drugs: How the Drug Delivery
More informationRFP for Workers Compensation Pharmacy Benefits Management Services
Minnesota Counties Insurance Trust Request for Proposals RFP for Workers Compensation Pharmacy Benefits Management Services JANUARY 30, 2007 TABLE OF CONTENTS I. General Information... 1 II. Proposal Timeframe...
More informationProposed Amendments: N.J.A.C. 11:4-37.2, 37.3, 37.4, and 37.6 and 11:22-5
INSURANCE DEPARTMENT OF BANKING AND INSURANCE DIVISION OF INSURANCE Selective Contracting Arrangements of Insurers, Minimum Standards for Network-Based Health Benefit Plans Proposed Amendments: N.J.A.C.
More informationPharmacy Benefit Manager Licensure and Solvency Protection Act
Pharmacy Benefit Manager Licensure and Solvency Protection Act Section 1. Title. This Act shall be known and cited as the Pharmacy Benefit Manager Licensure and Solvency Protection Act. Section 2. Purpose
More informationSTATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Senator NIA H. GILL District (Essex and Passaic) SYNOPSIS Regulates pharmacy benefits management companies. CURRENT
More information340B Drug Pricing Program
340B Drug Pricing Program Mary Stepanyan, PharmD Candidate 2018 University of Southern California, School of Pharmacy Pro Pharma Pharmaceutical Consultants Under the preceptorship of Dr. Craig Stern WHY
More informationUS Reimbursement Systems: Effects on R&D
US Reimbursement Systems: Effects on R&D Patricia M. Danzon, PhD Professor Emeritus The Wharton School University of Pennsylvania Theory: Optimal Reimbursement Rules to Create Efficient R&D Incentives
More informationSeptember 12, PreferredOne Insurance Company. Individual Comprehensive Medical Business. Rate Filing Justification
September 12, 2018 Individual Comprehensive Medical Business Rate Filing Justification Part Ill Actuarial Memorandum and Certification OVERVIEW This document contains the Part III Actuarial Memorandum
More information21 - Pharmacy Services
21 - Pharmacy Services The role of Health Plan of Nevada s (HPN) Pharmacy Services is to evaluate and determine the appropriateness of quality drug therapy while maintaining and improving therapeutic outcomes.
More informationA Guide to Healthcare Buzzwords and What They Mean: Part One (A through L)
A Guide to Healthcare Buzzwords and What They Mean: Part One (A through L) Welcome to our guide to Healthcare Buzzwords! ACO An acronym for Accountable Care Organization, an ACO is a model of healthcare
More informationFlorida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter July 1, 2016 through September 30, 2016
Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarter July 1, through September 30, Report to the Florida Legislature March 2018 [This page intentionally left blank.] Table
More informationPART 160_GENERAL ADMINISTRATIVE REQUIREMENTS--Table of Contents. Except as otherwise provided, the following definitions apply to this subchapter:
TITLE 45--PUBLIC WELFARE AND HUMAN SERVICES PART 160_GENERAL ADMINISTRATIVE REQUIREMENTS--Table of Contents Sec. 160.103 Definitions. Subpart A_General Provisions Except as otherwise provided, the following
More informationThe Value of Pharmacy Benefit Management And the National Cost Impact of Proposed PBM Legislation. Pharmaceutical Care Management Association
The Value of Pharmacy Benefit Management And the National Cost Impact of Proposed PBM Legislation Prepared for Pharmaceutical Care Management Association July 2004 Table of Contents I. Introduction and
More informationI. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:
I. PURPOSE The purpose of the Policy and Procedure is to ensure necessary continuity of treatment and to provide adequate time and transition process to introduce the enrollee and their prescribing physician
More informationMedicaid Prescribed Drug Program Spending Control Initiatives. For the Quarter April 1, 2014 through June 30, 2014
Medicaid Prescribed Drug Program Spending Control Initiatives For the Quarter April 1, 2014 through June 30, 2014 Report to the Florida Legislature January 2015 Table of Contents Purpose of Report... 1
More informationTable of Contents. Executive Resources, LLC 2015, v. 2
2 Table of Contents I. Introduction II. Overview III. Contract Pharmacy and Arrangements IV. HRSA and 340B Data Base V. Software, Internal Control Systems and Management of Inventory VI. External Relationships
More informationECONOMIC PRINCIPLES IMPACTING MANAGED CARE PHARMACY. Adrian Washington PharmD., MBA Vice President of Client Management United Healthcare OptumRx
ECONOMIC PRINCIPLES IMPACTING MANAGED CARE PHARMACY Adrian Washington PharmD., MBA Vice President of Client Management United Healthcare OptumRx As vice president, Adrian is responsible for strategic planning
More informationMEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers
MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE Reporting Requirements: Audit Preparedness for PDPs and Manufacturers Polaris Management Partners 8:30 9:30am Concurrent Breakout Session AGENDA
More informationKEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)
The Texas Association of Health Plans Representing health insurers, health maintenance organizations, and other related health care entities operating in Texas. KEEPING PRESCRIPTION DRUGS AFFORDABLE: The
More informationApril 8, Dear Mr. Levinson,
April 8, 2019 Daniel Levinson Office of Inspector General Department for Health and Human Services Cohen Building, Room 5527 330 Independence Ave, SW Washington, DC 20201 Re: Fraud and Abuse; Removal of
More information1 SB By Senator Marsh. 4 RFD: Banking and Insurance. 5 First Read: 19-MAY-15. Page 0
1 SB483 2 169136-1 3 By Senator Marsh 4 RFD: Banking and Insurance 5 First Read: 19-MAY-15 Page 0 1 169136-1:n:05/08/2015:MCS/mfc LRS2015-1981 2 3 4 5 6 7 8 SYNOPSIS: This bill would amend the Pharmaceutical
More informationWHITE PAPER How Consumer-Driven Healthcare Can Drive Down Costs for Payers
WHITE PAPER How Consumer-Driven Healthcare Can Drive Down Costs for Payers INTRODUCTION The United States healthcare system needs to confront one of its biggest issues head on the escalating cost of healthcare.
More informationBlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals
BlueRx PDP Conditions and Limitations Potential for Contract Termination Disenrollment Rights and Instructions Exceptions, Prior Authorization, Appeals and Grievances Out-of-Network Coverage Quality Assurance
More informationPharmacy Benefit Managers (PBMs)
Pharmacy Benefit Managers (PBMs) Reducing Costs and Improving Quality Lauren Rowley, VP State Affairs National Conference of State Legislatures May 18, 2018 Overview What is the problem? What is a PBM?
More informationProCare Rx/Jai Medical Systems Managed Care Organization 2018 Therapeutic Formulary
ProCare Rx/Jai Medical Systems Managed Care Organization 2018 Therapeutic Formulary This formulary describes the circumstances under which pharmacies participating in a particular medical benefit program
More informationUnderstanding PBM Quality. The 2 nd National Alliance PBM Report. John Miller
Understanding PBM Quality The 2 nd National Alliance PBM Report John Miller john.miller@mabgh.org 1 2 2 MARKET SHARE All Other 3% MedImpact 5% Prime Therapeutics 6% CVS/Caremark 25% Humana 7% Envision
More informationPrescription Drug Coverage
The Company s medical plans automatically include coverage for prescription drugs which is administered by Envision Pharmaceutical Services, Inc. (Envision Rx) for prescriptions filled at retail pharmacies
More informationINDUSTRY TRENDS IN PHARMACY REIMBURSEMENT
INDUSTRY TRENDS IN PHARMACY REIMBURSEMENT Heather Shouse, Sr. Director, Healthcare Solutions/ Inmar Jon Brumbaugh, Sr. Manager, Product, Healthcare / Inmar Disclosure We have no relationships with commercial
More information2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:
2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6 (HMO), Essentials Rx 14 (HMO), Essentials Rx 15 (HMO), Essentials Rx 16 (HMO), Essentials Rx 19 (HMO),
More informationWorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond. Kristin Begley, Pharm.D. Principal
WorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond Kristin Begley, Pharm.D. Principal Presentation Overview The future of drug trend Prescription drug management levers: Contracting
More informationWorkers Compensation Board Pharmacy Benefit Plan
1.0 Introduction Workers Compensation Board Pharmacy Benefit Plan Options for pharmaceutical care have greatly expanded over the past several years. New pharmaceuticals and pharmaceutical treatment modalities
More informationMAP AUPHA. Health Administration Press, Chicago, Illinois. Association of University Programs in Health Administration, Arlington, Virginia
SIXTH EDITION HEALTH LICY issues AN ECONOMIC PERSPECTIVE PAUL J. FELDSTEIN MAP AUPHA Health Administration Press, Chicago, Illinois Association of University Programs in Health Administration, Arlington,
More informationERM , Getzen Economics and Financing (Sec. 5.4, 5.5)
ERM 512-13, Getzen (Sec. 5.4, 5.5) 1/17 Key Points Types of Managed Care Plans Ways to Reduce Costs Features of Managed Care Utilization Review 2/17 Managed Care Plans Why Managed Care? Primary reason
More informationFlorida Medicaid Prescribed Drug Service Spending Control Initiatives
Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarters January 1, through March 31, and April 1, through June 30, Report to the Florida Legislature April 2018 [This page
More informationPrescription Drugs Spending Distribution and Cost Drivers. Steve Kappel January 25, 2007
Prescription Drugs Spending Distribution and Cost Drivers Steve Kappel January 25, 2007 Introduction Why Focus on Drugs? Compared to other health care spending: Even faster annual growth Higher reliance
More informationUPMC Pinnacle. Policy #C-667 Page 1 of 5. Charity Care and Financial Assistance Policy. Policy Statement:
UPMC Pinnacle Policy #C-667 Page 1 of 5 Subject: Charity Care and Financial Assistance Policy Policy Statement: It is the policy of the UPMC Pinnacle to consider each patient s ability to pay for his or
More informationPBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS*
PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS* Whereas: It is essential to understand the drivers and impacts of prescription drug costs, and transparency is the first step toward that
More informationCHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT
CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT 58-29E-1. Definition of terms. Terms used in this chapter mean: (1) "Covered entity," a nonprofit hospital or medical service corporation, health insurer, health
More informationH. R IN THE HOUSE OF REPRESENTATIVES
I 1TH CONGRESS 1ST SESSION H. R. 1 To ensure patient choice in pharmacies by regulating pharmacy benefit managers and to establish a program to improve access to prescription drugs for certain individuals.
More informationThe 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
The 2019 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers Adam J. Fein, Ph.D. Drug Channels Institute March 2019 Full report available at https://drugch.nl/pharmacy COPYRIGHT Copyright
More informationFlorida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter April 1, 2016 through June 30, 2016
Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarter April 1, through June 30, Report to the Florida Legislature December 2017 [This page intentionally left blank.] Table
More informationBlue care network pre authorization. Blue care network pre authorization
Paieška Paieška Paieška Blue care network pre authorization Blue care network pre authorization > > Blue Cross Complete (Medicaid) BCN Advantage HMO-POS Formulary Custom Formulary Prior Authorization and
More informationMedicaid Prescribed Drug Program. Spending Control Initiatives
Medicaid Prescribed Drug Program Spending Control Initiatives For Quarters Ended September 30, December 31, Table of Contents Purpose of Report... 1 Executive Summary... 2 Pharmacy Appropriations and Spending
More informationHow Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD
Improving care through shared knowledge How Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD $100 Total Healthcare Spend
More informationThe 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
The 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers Adam J. Fein, Ph.D. Drug Channels Institute February 2018 Full report available at http://drugch.nl/pharmacy COPYRIGHT Copyright
More informationNCPDP Electronic Prescribing Standards
NCPDP Electronic Prescribing Standards May 2014 1 What is NCPDP? An ANSI-accredited standards development organization. Provides a forum and marketplace for a diverse membership focused on health care
More informationValues Accountability Integrity Service Excellence Innovation Collaboration
n04231 Medicare Part D Transition and Emergency Fill Policy Values Accountability Integrity Service Excellence Innovation Collaboration Abstract Purpose: The Medicare Part D Transition and Emergency Fill
More informationY0076_ALL Trans Pol
Policy Title: Medicare Part D Transition Policy Policy Number: PCM-2018 TB Policy Owner: Antonio Petitta, Vice President Pharmacy Care Management Department(s): Pharmacy Care Management Effective Date:
More informationACCOUNTING AND FINANCE
ACCOUNTING AND FINANCE Michael Jones University of Bristol WILEY Contents About the Author About the Book Acknowledgements xv xvii xxiii 1 INTRODUCTION TO ACCOUNTING AND FINANCE 1 Introduction 2 Nature
More informationThe Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer s Perspective
International In-house Counsel Journal Vol. 4, No. 13, Autumn 2010, 1 The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer s Perspective LESLIE
More informationChapter 21. Pharmacy Services
Last Updated: 11/14/2018 1:52:00 PM Chapter 21 Pharmacy Services Definitions Compounded Prescription: A prescription prepared in accordance with Minnesota Rules 6800.3100. Dispensing Date: The actual date
More informationThe Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues
The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27, 2004 P w C Overview of Recent Medicare Act On December
More informationPhysical Address: (Number) (Street) (City) (State) (Zip Code) Date of ACO Formation Date of Incorporation:
APPLICATION for: Accountable Care Organization Errors and Omissions and Directors and Officers Liability Insurance Claims Made Basis. Underwritten by Underwriters at Lloyd s, London Notice: This is an
More informationChallenges in High Dollar Drugs. Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare
Challenges in High Dollar Drugs Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare Disclosure I have no relevant conflicts of interest to disclose Learning
More informationRe: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]
January 25, 2019 Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-4180-P P.O. Box 8013 Baltimore, MD 21244-8013 Re: Modernizing
More information2019 Transition Policy and Procedure
2019 Transition Policy and Procedure POLICY Steward Health Choice Generations (SHCG) provides a Part D drug transition process in order to prevent enrollee medication coverage gaps. SHCG s transition process
More informationCommunity Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018
Title: and H2034 HMO-SNP 2018 Policy Identifier: PA - Pharmacy Effective Date: 20180101 Scope: Organization Wide Family Care PACE Partnership Waukesha Day Center HUD (Housing and Urban Development) Department:
More informationNational Centre for Pharmacoeconomics. Guidelines for Inclusion of Drug Costs in Pharmacoeconomic Evaluations
National Centre for Pharmacoeconomics Guidelines for Inclusion of Drug Costs in Pharmacoeconomic Evaluations Version 1.13 Please Note: This document may be updated periodically, therefore please refer
More informationOECD HEALTH SYSTEM CHARACTERISTICS SURVEY 2012
OECD HEALTH SYSTEM CHARACTERISTICS SURVEY 2012 Emily Hewlett OECD Health Data National Correspondents and Health Accounts Experts Meeting, 17 th October 2013 Health System Characteristics Survey 2012 HSC
More informationTHIRD-PARTY PHARMACY RECONCILIATION
THIRD-PARTY PHARMACY RECONCILIATION Billy Caster Sales Solution Expert Inmar Healthcare Network Jon Brumbaugh Sr. Manager, Product Inmar Healthcare Network Session Description A discussion and presentation
More informationComments of Aetna Inc. before the Joint Public Hearing of the Florida Office of Insurance Regulation And the Florida health Insurance Advisory Board
Comments of Aetna Inc. before the Joint Public Hearing of the Florida Office of Insurance Regulation And the Florida health Insurance Advisory Board May 4, 2010 Mark LaBorde President, Jacksonville/Tampa
More informationTable of Contents. Texas Vendor Drug Program Overview Requirements Envolve Communication Notices...
Superior HealthPlan Table of Contents Texas Vendor Drug Program Overview 5 Requirements 6 Envolve Communication Notices.... 7-11 Superior HealthPlan Overview..14-23 Benefit Design.. 24 Envolve Pharmacy
More informationHARLEY-DAVIDSON REPORTS SECOND QUARTER 2016 EARNINGS
HARLEY-DAVIDSON REPORTS SECOND QUARTER 2016 EARNINGS Strong share gains in the U.S. in the face of industry headwinds, international sales up MILWAUKEE, July 28, 2016 Harley-Davidson, Inc. (NYSE:HOG) second
More informationClient Memorandum. OIG Approves Web-Based Advertising and Care Management Incentive Programs with Restrictions. Health Law September 2002.
Client Memorandum Health Law September 2002 OIG Approves Web-Based Advertising and Care Management Incentive Programs with Restrictions By James M. Jorling Background On August 30, 2002, the Department
More informationInside: Critical information about your company s prescription drug benefit.
Inside: Critical information about your company s prescription drug benefit. Questions Company Benefits Managers Must Ask Their PBM It pays to make an informed decision harmacy Benefit Managers, often
More information